Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older
- People who have been diagnosed with multiple myeloma
- People who are able to complete monthly questionnaires in Hebrew, Arabic, or Russian
- People who are willing and able to sign a consent form agreeing to take part
Who may not be able to join:
- People under the age of 18
- People who are due to receive acupuncture as part of the trial and have a platelet count (a blood measurement related to clotting) below 20x10⁹/L
- People who are due to receive reflexology as part of the trial and have a blood clot in a leg vein (deep vein thrombosis)
- People whose heart or blood circulation is unstable
- People who have a psychiatric condition that affects their ability to make informed decisions about taking part
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ilana Levy Yurkovski, MD, Bnai Zion Medical Center, Haifa, Israel
Phone: +972525086128
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Quality-of-life specific to myeloma patients
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.